About: Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.25 (-0.96%)
AVTX NASDAQ Avalo Therapeutics Inc
Avalo Therapeutics Inc share price
AVTX price activity
Last Price
$7.250
Change (24hr)
-0.07 USD (0.96%)
Volume
57.32K
Volume (4w avg)
-
Previous Close
$7.32
Last Trade
04 Nov, 2:10 pm GMT+0
Delayed
04 Nov, 2:10 pm GMT+0
AVTX price performance
Delayed
04 Nov, 2:10 pm GMT+0
AVTX details
AVTX Market Signals